Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Crinetics Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- 0 vs. Q3 2022
- Shares held
- 54.8M
- +3.36M (+6.5%) vs. Q3 2022
- Total value
- $1.00B
- −$7.67M (−0.8%) vs. Q3 2022
- New holders
- 13
- 45 more added
- Sold out
- 13
- 37 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 267 | $4.63B |
| Q1 2026 | 244 | $4.46B |
| Q4 2025 | 242 | $5.20B |
| Q3 2025 | 225 | $4.49B |
| Q2 2025 | 222 | $3.01B |
| Q1 2025 | 227 | $3.42B |
| Q4 2024 | 247 | $5.10B |
| Q3 2024 | 235 | $4.32B |
| Q2 2024 | 234 | $3.69B |
| Q1 2024 | 203 | $3.76B |
| Q4 2023 | 181 | $2.51B |
| Q3 2023 | 172 | $2.04B |
| Q2 2023 | 140 | $974.1M |
| Q1 2023 | 129 | $884.3M |
| Q4 2022 | 122 | $1.00B |
| Q3 2022 | 122 | $1.01B |
| Q2 2022 | 111 | $944.5M |
| Q1 2022 | 116 | $997.4M |
| Q4 2021 | 118 | $1.26B |
| Q3 2021 | 94 | $708.2M |
| Q2 2021 | 83 | $616.9M |
| Q1 2021 | 80 | $465.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Crinetics Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 732,000 | $13.4M | 4.66% | +60,700+9.0% | Added |
| Novo Holdings A/S | 737,057 | $13.5M | 0.84% | +105,430+16.7% | Added |
| Finepoint Capital LP | 822,745 | $15.1M | 4.87% | +822,745 | New |
| 5AM Venture Management, LLC | 862,286 | $15.8M | 4.24% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 890,105 | $16.3M | 1.91% | +370,849+71.4% | Added |
| Geode Capital Management, LLC | 921,230 | $16.9M | 0.00% | +38,135+4.3% | Added |
| Deep Track Capital, LP | 1,048,829 | $19.2M | 0.84% | −4,171−0.4% | Reduced |
| First Light Asset Management, LLC | 1,329,313 | $24.3M | 2.26% | −17,339−1.3% | Reduced |
| EcoR1 Capital, LLC | 1,330,263 | $24.3M | 0.74% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,361,000 | $24.9M | 0.09% | +50,800+3.9% | Added |
| Frazier Life Sciences Management, L.P. | 1,414,823 | $25.9M | 1.61% | 00.0% | Unchanged |
| FMR LLC | 1,883,118 | $34.5M | 0.00% | −798,485−29.8% | Reduced |
| State Street Corp | 2,004,784 | $36.7M | 0.00% | +196,119+10.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42.2M | 4.71% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,386,387 | $43.7M | 0.00% | +29,740+1.3% | Added |
| BVF Inc | 2,736,613 | $50.1M | 2.11% | −942,334−25.6% | Reduced |
| Wellington Management Group LLP | 2,804,485 | $51.3M | 0.01% | +171,474+6.5% | Added |
| OrbiMed Advisors LLC | 3,196,876 | $58.5M | 1.12% | 00.0% | Unchanged |
| Braidwell LP | 3,469,674 | $63.5M | 2.13% | +3,469,674 | New |
| BlackRock Inc. | 3,917,489 | $71.7M | 0.00% | +165,467+4.4% | Added |
| Perceptive Advisors LLC | 4,039,276 | $73.9M | 2.13% | −1,281,756−24.1% | Reduced |
| Driehaus Capital Management LLC | 5,624,744 | $102.9M | 1.53% | −7,214−0.1% | Reduced |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −735,716−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −90,460−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −28,500−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −26,753−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −24,509−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −3,138−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,925−100.0% | Sold out |
| Almanack Investment Partners, LLC. | 0 | $0 | 0.00% | −1,001−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |